The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Novo Nordisk A/S

NYSE: NVO
Last

(U.S.) $43.67

Today's change-0.13 -0.30%
Updated December 26 4:03 PM EST. Delayed by at least 15 minutes.
 

Novo Nordisk A/S

NYSE: NVO
Last

(U.S.) $43.67

Today's change-0.13 -0.30%
Updated December 26 4:03 PM EST. Delayed by at least 15 minutes.

Novo Nordisk A/S down (U.S.)$0.13

Novo Nordisk A/S closed lower Friday, dropping (U.S.)$0.13 or 0.30% to (U.S.)$43.67. Shares have lost 0.32% over the last five days, but have gained 18.18% over the last year to date. This security has outperformed the S&P 500 by 7.30% during the last year.

Key company metrics

  • Open(U.S.) $43.83
  • Previous close(U.S.) $43.80
  • High(U.S.) $43.88
  • Low(U.S.) $43.37
  • Bid / Ask-- / --
  • YTD % change+18.18%
  • Volume430,974
  • Average volume (10-day)1,433,228
  • Average volume (1-month)1,232,312
  • Average volume (3-month)1,534,911
  • 52-week range(U.S.) $35.92 to (U.S.) $49.11
  • Beta0.95
  • Trailing P/E27.22×
  • P/E 1 year forward25.57×
  • Forward PEG2.03×
  • Indicated annual dividend(U.S.) $0.83
  • Dividend yield1.90%
  • Trailing EPS(U.S.) $1.60
Updated December 26 4:03 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+30.79%

Based on its net profit margin of 30.79%, Novo Nordisk A/S is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.10%Sector:Industry:
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2014Q1/2014Q4/2013Q3/2013
Fiscal Quarter Endvalues in $ millions unless otherwise notedJun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013Sep 30, 201309/30/2013
Revenue21,62920,34321,69820,511
Total other revenue--------
Total revenue21,62920,34321,69820,511
Gross profit17,95816,87718,29816,986
Total cost of revenue3,6713,4663,4003,525
Total operating expense12,89612,31014,34412,519
Selling / general / administrative6,3545,8917,5576,351
Research & development3,0753,1683,5662,795
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total-204-215-179-152
Operating income8,7338,0337,3547,992
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax8,9898,3017,7908,299
Income after tax6,9946,4586,0536,415
Income tax, total1,9951,8431,7371,884
Net income6,9946,4586,0536,415
Total adjustments to net income--------
Net income before extra. items6,9946,4586,0536,415
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items6,9946,4586,0536,415
Inc. avail. to common incl. extra. items6,9946,4586,0536,415
Diluted net income6,9946,4586,0536,415
Dilution adjustment0------
Diluted weighted average shares2,6372,6532,6662,682
Diluted EPS excluding extraordinary itemsvalue per share2.652.432.272.39
Dividends per sharevalue per share0.000.003.350.00
Diluted normalized EPSvalue per share2.652.432.272.39